New York Medical College — Valhalla, New York

Public research footprint of New York Medical College, compiled from the ClinicalTrials.gov public registry.

410

Registered studies

Active

Recruiting now

271

Completed

Stopped or withdrawn

Most-studied conditions

B Acute Lymphoblastic Leukemia · Botryoid-Type Embryonal Rhabdomyosarcoma · Malignant Neoplasm · Recurrent Langerhans Cell Histiocytosis

Recently updated registry entries

NCT04320888 — Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic… (Active Not Recruiting)
NCT04166409 — A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With… (Recruiting)
NCT01503632 — Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at New York Medical College?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.